Literature DB >> 31019259

Deletion of self-reactive CCR7- thymocytes in the absence of MHC expression on thymic epithelial cells.

Rushika C Wirasinha1, Anna Chan1, Jin Yan Yap2, Daniel Y Hu2, Charis E Teh3,4, Daniel H D Gray3,4, Christopher C Goodnow5,6, Stephen R Daley7.   

Abstract

The selection of αβ T cells in the thymus is punctuated by checkpoints at which thymocytes differentiate or undergo apoptosis. Wave 1 deletion is defined as apoptosis within nascent αβ T-cell antigen receptor (TCR)-signalled thymocytes that lack CCR7 expression. The antigen-presenting cell (APC) types that mediate wave 1 deletion are unclear. To measure wave 1 deletion, we compared the frequencies of TCRβ + CD5 + Helios + CCR7- cells in nascent thymocyte cohorts in mice with normal or defective apoptosis. This thymocyte population is small in mice lacking major histocompatibility complex (MHC) expression. The scale of wave 1 deletion was increased by transgenic expression of the self-reactive Yae62 TCRβ chain, was almost halved when haemopoietic APCs lacked MHC expression and, surprisingly, was unchanged when epithelial cells lacked MHC expression. These findings demonstrate efficiency, and some redundancy, in the APC types that mediate wave 1 deletion in the normal mouse thymus.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31019259      PMCID: PMC7224288          DOI: 10.1038/s41418-019-0331-8

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  2 in total

1.  Cell expansion and growth arrest phases during the transition from precursor (CD4-8-) to immature (CD4+8+) thymocytes in normal and genetically modified mice.

Authors:  C Pénit; B Lucas; F Vasseur
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

2.  Normal sequence of phenotypic transitions in one cohort of 5-bromo-2'-deoxyuridine-pulse-labeled thymocytes. Correlation with T cell receptor expression.

Authors:  B Lucas; F Vasseur; C Penit
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

  2 in total
  6 in total

1.  Bcl-2 Is Necessary to Counteract Bim and Promote Survival of TCRαβ+CD8αα+ Intraepithelial Lymphocyte Precursors in the Thymus.

Authors:  Sharmila Shanmuganad; Sarah A Hummel; Vivian Varghese; David A Hildeman
Journal:  J Immunol       Date:  2022-01-07       Impact factor: 5.422

2.  How Thymocyte Deletion in the Cortex May Curtail Antigen-Specific T-Regulatory Cell Development in the Medulla.

Authors:  Chenglong Wang; Stephen R Daley
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

3.  DOCK8 deficiency diminishes thymic T-regulatory cell development but not thymic deletion.

Authors:  Katrina L Randall; Hsei Di Law; Andrew F Ziolkowski; Rushika C Wirasinha; Christopher C Goodnow; Stephen R Daley
Journal:  Clin Transl Immunology       Date:  2021-01-07

4.  Covalent TCR-peptide-MHC interactions induce T cell activation and redirect T cell fate in the thymus.

Authors:  Christopher Szeto; Pirooz Zareie; Rushika C Wirasinha; Justin B Zhang; Andrea T Nguyen; Alan Riboldi-Tunnicliffe; Nicole L La Gruta; Stephanie Gras; Stephen R Daley
Journal:  Nat Commun       Date:  2022-08-23       Impact factor: 17.694

5.  A role for phagocytosis in inducing cell death during thymocyte negative selection.

Authors:  Nadia S Kurd; Lydia K Lutes; Jaewon Yoon; Shiao Wei Chan; Ivan L Dzhagalov; Ashley R Hoover; Ellen A Robey
Journal:  Elife       Date:  2019-12-23       Impact factor: 8.140

6.  Nfkb2 variants reveal a p100-degradation threshold that defines autoimmune susceptibility.

Authors:  Rushika C Wirasinha; Ainsley R Davies; Monika Srivastava; Julie M Sheridan; Xavier Y X Sng; Ottavia M Delmonte; Kerry Dobbs; Khai L Loh; Lisa A Miosge; Cindy Eunhee Lee; Rochna Chand; Anna Chan; Jin Yan Yap; Michael D Keller; Karin Chen; Jamie Rossjohn; Nicole L La Gruta; Carola G Vinuesa; Hugh H Reid; Michail S Lionakis; Luigi D Notarangelo; Daniel H D Gray; Christopher C Goodnow; Matthew C Cook; Stephen R Daley
Journal:  J Exp Med       Date:  2021-02-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.